Grace Therapeutics, Inc. (GRCE)
EBITDA Margin
0.00%
Quarterly · Period ending:
GRCE EBITDA Margin
Latest reported0.00%period ending
Latest reported0.00%period ending
GRCE Quarterly EBITDA Margin (0.00% → 0.00%)
Quarterly ebitda margin
High-resolution chart · PNG
GRCE ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -4,908.8904% | |
| -2,424.7132% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -6,307.186% | |
| -31,324.7232% | |
| -9,216.0076% | |
| -7,313.6966% | |
| -1,148.2754% | |
| 12,480.733% | |
| -41,463.58% | |
| 3,458.9229% | |
| -1,253.4572% | |
| -9,290.3446% | |
| -1,027.625% | |
| -28,157.6569% | |
| -5,844.297% | |
| -340.2919% | |
| -668.2191% | |
| -10,315.2407% | |
| -10,410.129% | |
| 0% | |
| 0% | |
| -1,031.5286% | |
| -3,482.4483% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |